NHTC
NATURAL HEALTH TRENDS CORP
Next earnings Jul 28, 2026
Last earnings -0.7% on 2026-04-29
$1.55
▲ 0.00%$1.55▼ -59.38%
over 1Y
L $1.55EODHDH $4.27
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W-7.2%
1M-43.0%
3M-42.4%
YTD-46.6%
1Y-59.4%
Avoid
Conviction
Horizon
Medium (3–12mo)
Conservative balance sheet (liabilities/equity 0.64x); but revenue declined -7.4% YoY.
NATURAL HEALTH TRENDS CORP shows $39.8M in FY2025 revenue (-7.4% YoY), a -2.2% net margin, and -3.8% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $60.0M | $49.1M | $43.9M | $43.0M | $39.8M |
| Gross profit | $45.0M | $36.5M | $32.7M | $31.8M | $29.3M |
| Operating income | $1.57M | -$270K | -$1.67M | -$1.30M | -$1.81M |
| Net income | $1.08M | $313K | $568K | $572K | -$882K |
| Diluted EPS | $0.09 | $0.03 | $0.05 | $0.05 | -$0.08 |
| Net margin | 1.8% | 0.6% | 1.3% | 1.3% | -2.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$6.48M
EV / EBITDA—
EV / Sales0.2
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-6.6%
FCF yield-45.6%
Quality & risk
ROIC (est.)-6.1%
Free cash flow-$6.07M
Total debt—
Net cash$6.81M
Altman Z-Score0.72 distress
Piotroski F-Score3/8
Capital returns
Buyback yield0.0%
Dividend yield (est.)69.3%
Shareholder yield69.3%
Shares Δ YoY-25.5%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗3Period ending 2026-05-072026-06-08open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-04-29open ↗8-KPeriod ending 2026-04-292026-04-29open ↗ARSPeriod ending 2025-12-312026-03-30open ↗DEF 14APeriod ending 2026-05-072026-03-24open ↗DEFA14AFiling2026-03-24open ↗DEF 14APeriod ending 2026-05-072026-03-24open ↗10-KPeriod ending 2025-12-312026-02-20open ↗SCHEDULE 13DFiling2026-02-18open ↗8-KPeriod ending 2026-02-172026-02-17open ↗8-KPeriod ending 2026-02-042026-02-04open ↗
Frequently asked
- Is NATURAL HEALTH TRENDS CORP (NHTC) a buy?
- NHTC currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.64x); but revenue declined -7.4% YoY.
- What is NATURAL HEALTH TRENDS CORP's quality score?
- NHTC scores 48.76470588235294/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000912061, latest 10-Q filed 2026-04-29) · EODHD · as of 6/26/2026, 8:08:46 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.